ADAMIS ANTHONY P 4
4 · EyePoint Pharmaceuticals, Inc. · Filed Jun 25, 2024
Insider Transaction Report
Form 4
ADAMIS ANTHONY P
Director
Transactions
- Exercise/Conversion
Common Stock
2024-06-23+2,000→ 4,000 total - Exercise/Conversion
Restricted Stock Units
2024-06-23−2,000→ 2,000 totalExercise: $0.00→ Common Stock (2,000 underlying)
Footnotes (1)
- [F1]The restricted stock units vests in three ratable annual installments beginning June 23, 2023.